Evidence map›Paper›PMID 22662179›Full record

ArticlePloS one2012

Moraxella catarrhalis activates murine macrophages through multiple toll like receptors and has reduced clearance in lungs from TLR4 mutant mice.

Ferdaus Hassan, Dabin Ren, Wenhong Zhang, Tod J Merkel, Xin-Xing Gu

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Role of the Microbiome in Allergic Disease Development.Current allergy and asthma reports · 2020
    Review
  9. Panel 6: Vaccines.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2017
    Review
  10. IL-17 and TNF-α Are Key Mediators ofFrontiers in immunology · 2017
    Article
  11. Association of microRNA 146 with middle ear hyperplasia in pediatric otitis media.International journal of pediatric otorhinolaryngology · 2016
    Article
  12. Vaccine targets against Moraxella catarrhalis.Expert opinion on therapeutic targets · 2016
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ferdaus HassanVaccine Research Section, National Institute on Deafness and Other Communication Disorders, Rockville, Maryland, United States of America. hassanmf@umkc.edu
Dabin Ren
Wenhong Zhang
Tod J Merkel
Xin-Xing Gu
National Institute on Deafness and Other Communication Disorders · USCenter for Biologics Evaluation and Research · US

Funding

Intramural NIH HHSPHS HHS 0010103632
6 · The paper itself

Abstract

Moraxella catarrhalis is a gram negative bacterium and a leading causative agent of otitis media (OM) in children. Several recent reports have provided strong evidence for an association between toll like receptors and OM. It has been found that both Streptococcus pneumoniae and nontypeable Haemophilus influenzae activate host protective immune responses through toll like receptors (TLRs), however, the precise mechanism by which Moraxella catarrhalis initiates the host immune response is currently unknown. In this report, using murine macrophages generated from a series of knock-out mice, we have demonstrated that M. catarrhalis lipooligosaccharide (LOS) and either heat killed or live bacteria are recognized by one or more TLRs. LOS activates the host immune response through a membrane bound CD14-TLR4 complex, while both heat killed and live M.cat require recognition by multiple toll like receptors such as TLR2, TLR4 and TLR9 without the requirement of CD14. We have also shown that M.cat stimuli are capable of triggering the host innate immune response by both MyD88- and TRIF- dependent signaling pathways. We further showed that M.cat induced activation of mitogen activated protein kinase (MAPK) is essential in order to achieve optimal secretion of pro-inflammatory cytokine TNF-α. We finally showed that TLR4 mutant C3H/HeJ mice produce significantly lower levels of pro-inflammatory cytokines TNF-α and IL-6 in vivo, An increased bacterial loads at 12 and 24 hours (P<0.001) in their lungs upon challenge with live M.cat in an aerosol chamber compared to wild-type (WT) control mice. These data suggest that TLRs are crucial for an effective innate immune response induced by M.cat. The results of these studies contribute to an increased understanding of molecular mechanism and possible novel treatment strategies for diseases caused by M.cat by specifically targeting TLRs and their signaling pathways.

Indexed as

Adaptor Proteins, Vesicular TransportAnimalsCytokinesFemaleLipopolysaccharide ReceptorsLipopolysaccharidesLungMacrophage ActivationMacrophagesMiceMice, Inbred C3HMice, KnockoutMitogen-Activated Protein KinasesMoraxella catarrhalisMutationMyeloid Differentiation Factor 88Adaptor Proteins, Vesicular TransportCytokineslipid-linked oligosaccharidesLipopolysaccharide ReceptorsLipopolysaccharidesMitogen-Activated Protein KinasesMyeloid Differentiation Factor 88Ticam1 protein, mouseToll-Like Receptor 2Toll-Like Receptor 4Toll-Like Receptor 9Toll-Like Receptors

Identifiers

PMID22662179
PMCPMC3360749
OpenAlexW1969792797

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.